Administration Routes in Research Multiple delivery methods have been investigated for individual peptides: Intraperitoneal injection Most common in rodent studies for both peptides Subcutaneous injection Used in some clinical observations (not controlled trials) Intramuscular injection Applied in musculoskeletal research protocols Oral administration Uniquely effective for BPC-157
Terms & Conditions NovaCell Peptides NovaCell Terms and Conditions for the purchase of research peptides
Community research-use guides suggest a subcutaneous range of about 100200 mcg (overall roughly 50200 mcg), reconstituted with bacteriostatic water only [12]
Also see the evidence for other ingredients promoted for osteoarthritis and our Top Pick supplements for joints in our Joint Health Supplements Review
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial